Growing Market Presence iHealthScreen has recently expanded its operations in Bangladesh, obtaining MHRA certification for its AI-powered screening system and launching new health services in collaboration with local health authorities, indicating a strategic push into emerging markets.

Funding Momentum The company has secured over 8 million dollars in seed and pre-Series A funding rounds in 2023, highlighting investor confidence and providing financial agility for scaling sales efforts and broadening product reach.

Innovative Technology Utilizing AI-driven diagnostics for eye and systemic disease screening, iHealthScreen’s advanced software offers early detection solutions that address healthcare providers seeking modern, cost-effective diagnostic tools.

Regulatory Approvals Recent certification achievements such as MHRA approval demonstrate regulatory success, enabling the company to target international markets and healthcare institutions requiring certified medical devices.

Market Diversification With a focus on under-resourced areas and collaborations with associations like DAB, iHealthScreen presents opportunities for healthcare providers and NGOs to adopt affordable, AI-powered screening services aligned with global health initiatives.